LEGALDIGMLEGALDIGM
    ← Code of Federal Regulations
    Beta
    21 CFR § 314.162

    21 CFR § 314.162 — § 314.162 Removal of a drug product from the list.

    Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.

    Analyze this law with AI
    § 314.162 Removal of a drug product from the list. (a) FDA will remove a previously approved new drug product from the list for the period stated when: (1) The agency withdraws or suspends approval of a new drug application or an abbreviated new drug application under § 314.150(a) or § 314.151 or under the imminent hazard authority of section 505(e) of the act, for the same period as the withdrawal or suspension of the application; or (2) The agency, in accordance with the procedures in § 314.153(b) or § 314.161, issues a final decision stating that the listed drug was withdrawn from sale for safety or effectiveness reasons, or suspended under § 314.153(b), until the agency determines that the withdrawal from the market has ceased or is not for safety or effectiveness reasons. (b) FDA will publish in the Federal Register a notice announcing the removal of a drug from the list. (c) At the end of the period specified in paragraph (a)(1) or (a)(2) of this section, FDA will relist a drug that has been removed from the list. The agency will publish in the Federal Register a notice announcing the relisting of the drug. [57 FR 17996, Apr. 28, 1992]

    Related guides, FAQ and contract templates